Aquestive Therapeutics Inc
AQST3.915USD
+0.095+2.49%
交易中 （美東）報價延遲15分鐘
388.83M總市值
虧損本益比TTM
關於 Aquestive Therapeutics Inc 公司
Aquestive Therapeutics, Inc. 是一家制藥公司。該公司正在開發藥品，通過給藥方式輸送複雜分子，以替代侵入性和不方便的標準護理療法。該公司正在推進治療嚴重過敏反應（包括過敏反應）的產品線。該公司還開發了專注於治療中樞神經系統 (CNS) 疾病的產品線。其 PharmFilm 技術由專有聚合物組合物組成，這些組合物可用作成膜劑來固定活性藥物成分 (API) 和賦形劑。其產品組合和產品線包括 Anaphylm、AQST-108 和 Adrenaverse。其 CNS 候選產品包括 Libervant。該公司的許可商業產品和候選產品及其他產品包括 Suboxone、Exservan、KYNMOBI、Zuplenz、Azstarys、Libervant 和 Sympazan。Anaphylm 是一種非基於設備的口服腎上腺素候選產品。
公司簡介
公司代碼AQST
公司名稱Aquestive Therapeutics Inc
上市日期Jul 25, 2018
CEOMr. Daniel Barber
員工數量142
證券類型Ordinary Share
年結日Jul 25
公司地址30 Technology Dr
城市WARREN
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編07059-5166
電話19089411900
網址https://aquestive.com/
公司代碼AQST
上市日期Jul 25, 2018
CEOMr. Daniel Barber
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
313.57K
+24.59%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
303.11K
+27.67%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
293.84K
+26.99%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
156.86K
-1.70%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Dr. Marco Taglietti, M.D.
Dr. Marco Taglietti, M.D.
Independent Director
Independent Director
--
--
Mr. Timothy E. Morris, CPA
Mr. Timothy E. Morris, CPA
Independent Director
Independent Director
--
--
Ms. Stephanie Carrington
Ms. Stephanie Carrington
Investor Relations
Investor Relations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.85M
+33.44%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
649.24K
+36.11%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
313.57K
+24.59%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
303.11K
+27.67%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
293.84K
+26.99%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
156.86K
-1.70%
收入明細
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
暫無數據
地區USD
名稱
營收
佔比
United States
5.20M
0.00%
Ex-United States
3.52M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 5月23日 週五
更新時間: 5月23日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Crestline Investors, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.48%
The Vanguard Group, Inc.
4.10%
Perceptive Advisors LLC
3.75%
Armistice Capital LLC
2.77%
Other
74.02%
持股股東
持股股東
佔比
Crestline Investors, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.48%
The Vanguard Group, Inc.
4.10%
Perceptive Advisors LLC
3.75%
Armistice Capital LLC
2.77%
Other
74.02%
股東類型
持股股東
佔比
Investment Advisor
16.61%
Hedge Fund
16.46%
Individual Investor
6.00%
Investment Advisor/Hedge Fund
5.80%
Private Equity
5.10%
Research Firm
4.75%
Bank and Trust
0.10%
Venture Capital
0.08%
Pension Fund
0.02%
Other
45.09%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
267
54.56M
54.93%
-2.83M
2025Q1
270
54.42M
54.80%
-3.81M
2024Q4
246
52.68M
57.78%
-5.60M
2024Q3
235
56.04M
61.46%
+1.93M
2024Q2
197
48.34M
53.08%
-1.69M
2024Q1
166
46.95M
51.85%
+18.59M
2023Q4
129
27.01M
40.12%
+751.99K
2023Q3
131
26.75M
41.08%
+3.52M
2023Q2
143
22.79M
40.65%
+3.05M
2023Q1
161
18.71M
33.39%
-2.52M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Crestline Investors, Inc.
9.81M
9.88%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.44M
5.48%
-78.94K
-1.43%
Mar 31, 2025
The Vanguard Group, Inc.
4.07M
4.1%
-273.20K
-6.29%
Mar 31, 2025
Perceptive Advisors LLC
3.73M
3.75%
+3.73M
--
Mar 31, 2025
Armistice Capital LLC
2.75M
2.77%
+2.75M
--
Sep 30, 2024
Barber (Daniel)
1.85M
1.86%
+462.91K
+33.44%
Mar 21, 2025
Geode Capital Management, L.L.C.
1.70M
1.71%
+46.11K
+2.79%
Mar 31, 2025
State Street Global Advisors (US)
1.52M
1.53%
+18.76K
+1.25%
Mar 31, 2025
Pale Fire Capital SE
1.34M
1.34%
+809.93K
+154.05%
Mar 31, 2025
BofA Global Research (US)
1.33M
1.34%
+640.24K
+92.75%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.55%
iShares Micro-Cap ETF
0.06%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.55%
iShares Micro-Cap ETF
佔比0.06%
Invesco Nasdaq Biotechnology ETF
佔比0.04%
ProShares Ultra Nasdaq Biotechnology
佔比0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
